baber/WOPTO huggingface dataset:
Patent NZ-529698-A (NZ)
Title: Apparatus for conditioning air
Inventor: FORKOSH MORDECHAI
IPC: F24F3/14
Filed: 2001-04-23
Abstract: A dehumidification method comprising: providing a liquid desiccant (20) at a first location (18); removing moisture from the liquid desiccant at the first location to a first source of air (22, 24); providing liquid desiccant (20') at a second location (18'), said liquid desiccant at said second location (18') being in fluid communication with the liquid desiccant at the first location (18); absorbing moisture by the liquid desiccant at the second location from a second source of air (22', 24'); and transferring moisture from the first location (18) to the second location (18') substantially only by diffusion and gravity.
Patent NZ-530928-A (NZ)
Title: Optical sensor containing particles for in situ measurement of analytes
Inventor: PETERSSON BO
IPC: G01N33/483
Filed: 2002-06-27
Abstract: A sensor for in vivo measurement of an analyte. The sensor comprises a plurality of particle of a size such that when they are implanted in the body of a mammal the particles can be ingested by macrophages and transported away from the site of implantation. Each particle contains components of an assay having a readout which is an optical signal detectable or measurable transdermally by external optical means. Each particle is also contained within a biodegradable gel.
Patent NZ-531641-A (NZ)
Title: Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol
Inventor: KESTELEYN BART RUDOLF ROMANIE
IPC: A61P43/00
Filed: 2002-09-06
Abstract: A method for the preparation of hexahydro-furo[2,3-b]furan-3-ol of formula (7) as well as intermediates for use in the method are disclosed, wherein the method relates to a stereoselective method for the preparation of hexahydro-furo[2,3-b]furan-3-ol, in which the stereochemistry of the intermediates or the final compound is controlled, which allows the synthesis of the stereoisomers of hexahydro-furo[2,3-b]furan-3-ol. This method is amenable to industrial scaling up.
Patent NZ-532070-A (NZ)
Title: GroEL Chimeric Protein and vaccine
Inventor: VANNIASINKAM THIRU
IPC: C07K19/00
Filed: 2002-10-25
Abstract: A chimeric GroEL protein is provided which includes a surface exposed exogenous amino acid sequence, which comprises an antigenic determinant of, for example, a pathogenic micro-organism. The exogenous amino acid sequence might be inserted into a hydrophilic region of the GroEL protein to provide a means of exhibiting the antigenic determinant to elicit an immune response specifically reactive to the antigenic determinant. This provides for a cellular bias to the elicited immune response and is thus is likely to be particularly useful for intracellular parasites.
Patent NZ-533707-A (NZ)
Title: The liquid composition for promoting plant growth, which includes nano-particle titanium dioxide
Inventor: CHOI KWANG-SOO
IPC: C05D9/02
Filed: 2002-11-16
Abstract: Disclosed is a liquid agricultural composition for promoting plant growth by promoting photosynthesis of plants, which contains colloidal titanium dioxide nanoparticles as an active ingredient, wherein the titanium dioxide nanoparticles have a particle size ranging from 3 to 200 nm for absorption into the foliage of plants. A pH of the aqueous solution is adjusted in order to prevent rapid precipitation of the titanium dioxide nanoparticles in the aqueous solution, before the aqueous solution is diluted with water such that titanium dioxide has a desired concentration. Also, the composition contains adjuvants necessary for plant growth and a surfactant for dispersion.
Patent NZ-534164-A (NZ)
Title: Cylinder lock
Inventor: MCNEIL PAUL
IPC: E05B27/02
Filed: 2004-07-16
Abstract: A cylinder lock for use in controlling operation of a latch assembly includes a cylinder body, an actuator assembly located in the cylinder body and a lock means including a barrel assembly. The lock means when the lock condition renders the actuator assembly inoperable.
Patent NZ-538841-A (NZ)
Title: Compositions for reducing hsp27 for the treatment of prostate and other cancers
Inventor: GLEAVE MARTIN E
IPC: A61P35/00
Filed: 2003-10-02
Abstract: A composition comprises oligonucleotide having a sequence complementary to a portion of SEQ ID NO:91 as a therapeutic agent effective to reduce the amount of active hsp27 in hsp 27 expressing cells. The oligonucleotide is an antisense oligonucleotide or a siRNA. The composition can be used in the manufacture of a medicament for the treatment of cancer.
Patent NZ-540487-A (NZ)
Title: Patient cooling system
Inventor: BEARD MARK
IPC: A61G10/00
Filed: 2003-11-05
Abstract: A patient cooling system comprises a patient enclosure or tent (2) having a coaxial hose connection (46, 4, 6) to a re-circulating air-cooling system (16, 18, 24). The hose comprises an inner tube (4) to introduce air into the enclosure and an outer tube (16) for the return air. Radially collapsible, sleeved openings (76) in the tent panel enable connection of conduits or patient care lines to the patient.
Patent NZ-541496-A (NZ)
Title: Catchment means to enable water precipitate collection from an upper surface of a water storage receptacle
Inventor: LEONARD JONATHAN
Filed: 2005-07-28
Abstract: Catchment apparatus 48 has dome-shaped collection surface 50 and is fitted over a roof 54 of an existing water tank 24. The apparatus has gutters 52 which convey water to an inlet 58 of tank 24.
Patent NZ-542169-A (NZ)
Title: Systems, methods, and interfaces for providing personalized search and information access
Inventor: HORVITZ ERIC J
IPC: G06F17/30
Filed: 2005-09-02
Abstract: A system that facilitates generating personalised searches of information is disclosed. The system includes a user model (120) to determine characteristics of a user, a personalisation component (110) to automatically modify at least one query component, and at least one search result in view of the user model (120). The query modification (170) and the result modification (160) are combined and dependencies are introduced among the two modifications and leveraged. An interface component (150) is provided to receive the query and display the search result.
Patent NZ-549354-A (NZ)
Title: Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof
Inventor: KAY PETER HAMILTON
IPC: C12Q1/68
Filed: 2005-02-03
Abstract: Disclosed is a method for identifying candidate genes capable of producing hybrid vigour in an animal or plant, comprising the steps of: (i) comparing the nucleotide sequence of alleles of candidate genes isolated from an animal or plant which exhibits hybrid vigour with the nucleotide sequences from the corresponding alleles isolated from the parents of said animal or plant; (ii) identifying nucleotide sequence differences in the alleles from said animal or plant which exhibits hybrid vigour which codes for amino acid sequence variation; and (iii) identifying that the amino acid sequence variation between alleles of the candidate gene in said animal or plant is encoded by nucleotide sequences which are located within two or more different exons within the candidate gene.
Patent NZ-550944-A (NZ)
Title: Dairy components effective for fat loss
Inventor: ZEMEL MICHAEL B
IPC: A61K38/38
Filed: 2005-03-29
Abstract: Disclosed is the use of a calcium containing whey product in the manufacture of a medicament for treating weight-related disorders and maintaining muscle mass and increasing the metabolic consumption of adipose tissue in an individual regulating body weight.
Patent NZ-551461-A (NZ)
Title: Electrical umbrella and canopy mechanism
Inventor: AMSEL CHAIM SIMCHA
IPC: A45B25/10
Filed: 2005-05-01
Abstract: A canopy conducting mechanism for hand held umbrellas is provided. It includes: a canopy conducting member having a number of a first part of pin and slide joints rigidly connected and angularly spaced about a common central hub; a spacer having a central lower end for being connected to a pole of an umbrella; and a number of pivot connection points remotely and angularly spaced about the central lower end. Each pivot connection point is adapted for receiving a pivot point of a canopy rib having a short lever arm, being the rib portion between the close rib end and the pivot point. The short lever arm has a second part of pin and slid joint matching the first part. The pin and slide joints have slides that are separated from one another by being formed in angularly spaced bars or cells.
Patent NZ-555172-A (NZ)
Title: Method for the preparation of sevoflurane from sevochlorane using a phase transfer catalyst
Inventor: TERRELL ROSS C
IPC: C07C43/13
Filed: 2005-11-17
Abstract: Disclosed is a process for preparing the compound (CF3)2CHOCH2F, (also known as sevoflurane), the method involving forming a reaction mixture of the precursor (CF3)2CHOCH2Cl, (also known as sevochlorane), potassium fluoride, water, and a phase transfer catalyst selected from quaternary ammonium salts, quaternary phosphonium salts, crown ethers, ionic liquids, and chiral compounds, with the proviso that an organic co-solvent is not present. Further suitable conditions such as temperature, pressure, and particular catalysts are disclosed.
Patent NZ-556038-A (NZ)
Title: Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol
Inventor: GUTMAN ARIE L
IPC: A61K31/353
Filed: 2005-11-18
Abstract: Disclosed is a method of preparing a trans-(-)-delta9-tetrahydrocannabinol composition, comprising: allowing a compositing comprising (+/-)-delta9-tetrahydrocannabinol and an eluting solvent to separate on a chiral stationary phase to provide a trans-(-)-delta9-tetrahydrocannabinol composition, or a trans-(+)-delta9-tetrahydrocannabinol composition, comprising: allowing a composition comprising (+/-)-delta9-tetrahydrocannabinol and an eluting solvent to separate on a chiral stationary phase to provide a trans-(+)-delta9-tetrahydrocannabinol composition, wherein the (+/-)-delta9-tetrahydrocannabinol is obtained from crystalline (+/-)-delta9-tetrahydrocannabinol, and wherein the crystalline (+/-)-delta9-tetrahydrocannabinol is obtained by allowing trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol to crystallize from a first composition comprising trans-(-)-delta9-tetrahydrocannabinol, trans-(+)-delta9-tetrahydrocannabinol and a non-polar organic solvent to provide crystalline (+/-)-delta9-tetrahydrocannabinol, wherein the first composition was obtained by a) forming a biphasic composition comprising (i) a first organic phase and (ii) an alcoholic-caustic phase containing the trans-(-)-delta9-tetrahydrocannabinol and/or the trans-(+)-delta9-tetrahydrocannabinol; b) separating the trans-(-)-delta9-tetrahydrocannabinol and/or the trans-(+)-delta9-tetrahydrocannabinol from the alcoholic-caustic phase; and c) forming a first composition comprising the trans-(+)-delta9-tetrahydrocannabinol, trans-(-)-delta9-tetrahydrocannabinol, and a non-polar solvent.
Patent NZ-561401-A (NZ)
Title: Acrylate/methacrylate adhesives initiated by chlorosulfonated polymer
Inventor: WANG XIAOBIN
IPC: C08F255/02
Filed: 2006-03-08
Abstract: Disclosed is a two-part adhesive formulation, comprising: A first part and a second part separate from the first part, wherein: the first part comprises an acrylate monomer or a methacrylate monomer, or a combination thereof; and a chlorosulfonated polymer resin; and the second part comprises a reducing agent, and a cure profile regulator comprising a cycloheteroatom zirconate or a cycloheteroatom titannate, or a combination thereof. Also disclosed is a method of manufacturing and a method of using the said adhesive formulation.
Patent NZ-567149-A (NZ)
Title: IV catheter with in-line valve and methods related thereto
Inventor: BELLEY RICHARD A
IPC: A61M5/178
Filed: 2006-10-11
Abstract: An in-line valve device is disclosed. The in-line valve device includes a housing, a tubular member, a seal member, and a securing member. The housing includes a proximal portion, a distal portion, and a chamber extending between the proximal and distal portions. The proximal portions include a proximal opening fluidly coupled to the chamber. The tubular member is coupled to the housing distal portion such that a lumen is fluidly coupled to the chamber. A seal member is disposed within the chamber to seal the proximal opening from the chamber, where the proximal opening is selectively fluidly coupled to the chamber by moving a sealing portion of the seal member out of engagement with the proximal portion of the housing to create a flow path about the seal member. The securing member is positioned to secure a distal end of the seal member to the housing proximal portion such that the seal member is compressibly retained between a proximal end of the chamber and the securing member.
Patent NZ-571591-A (NZ)
Title: Use of rasagiline for the treatment of restless legs syndrome
Inventor: BLAUGRUND ERAN
IPC: A61K31/16
Filed: 2007-03-30
Abstract: Disclosed is the use of R(+)-N-propargyl-1-aminoindan (rasagiline) or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of, or alleviation of symptoms of, Restless Legs Syndrome, wherein the symptoms are tingling in the legs, cramps in the legs, pain in the legs or restlessness in the legs..
Patent NZ-573196-A (NZ)
Title: Cushion for a respiratory mask assembly with two force applying features for respectively low and high mask pressure
Inventor: LITHGOW PERRY DAVID
IPC: A61M16/08
Filed: 2003-09-05
Abstract: A respiratory mask assembly for delivering breathable gas to a patient includes a frame and a cushion (14). The cushion (14) has a non-face contacting portion structured to be connected to the frame, a face-contacting portion (26) structured to engage the patient's face, and an intermediate portion (28) that interconnects the non-face contacting portion and the face-contacting portion (26). The intermediate portion (28) includes a gusset portion that extends radially outwardly and provides a footprint area greater than a contact line of the cushion and applies a first component of force to the patient's face through the face-contacting portion (26). A spring structure is coupled with the face-contacting portion (26) of the cushion (14). The spring structure applies a second component of force to the patient's face through the face-contacting portion (26). The first and second components of force applied by the gusset portion and spring structure, respectively, determine a contact force of the cushion (14) applied to the patient's face through the face-contacting portion (26). The spring structure provides sealing at relatively low mask pressure and the gusset portion increases contact force at relatively high mask pressure. The intermediate portion (28) may also include an elastic cuff portion. Further, in the case of an oral mask, the sealing section may include a portion that is designed to promote a better seal in the chin region of the mask.
Patent NZ-580162-A (NZ)
Title: Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
Inventor: SINHA UMA
IPC: A61K31/44
Filed: 2008-04-11
Abstract: Disclosed herein is the use of a compound which is [2-({ 4-[(dimethylamino)iminomethyl]phenyl} carbonylamino)-5-methoxyphenyl]-N-(5-chloro(2-pyridyl))carboxamide and a P2Y12 receptor antagonist in the manufacture of a medicament for treating a condition in a mammal characterized by undesired thrombosis, wherein the medicament is formulated for separate, sequential or simultaneous administration of the compound and the P2Y12 receptor antagonist, and wherein the P2Y12 receptor antagonist is selected from the group consisting of cangrelor, ticagrelor, clopidogrel, ticlopidine and prasugrel. Optionally comprising a third therapeutic agent selected from the group consisting of an antiplatelet agent, an anti-coagulant, a thrombin inhibitor, a thrombolytic agent, an antiarrhythmic agent, a blood pressure lowering agent, a cholesterol and a triglyceride lowering agent.
Patent NZ-582494-A (NZ)
Title: Multilayer plastic film having gas barrier properties for food packaging
Inventor: AUBEE NORMAN DORIEN JOSEPH
IPC: B65D71/06
Filed: 2008-07-09
Abstract: Disclosed are multilayer barrier films which have excellent Water Vapor Transmission Rate (WVTR) performance are prepared using a core layer which comprises a blend of two different high density polyethylenes (HDPEs) and a nucleating agent. The films are suitable for the preparation of packages for dry foods such as crackers and breakfast cereals. Particularly disclosed is a barrier film comprising a core layer and two skin layers, wherein said core layer consists essentially of a blend of: (a) a first high density polyethylene resin; (b) a second high density polyethylene resin having a melt index, I2, at least 50% greater than said first high density polyethylene resin; and (c) a barrier nucleating agent, wherein said blend has a melt index, I2, of from 0.5 to 10 grams/10 minutes.
Patent NZ-582817-A (NZ)
Title: Three dimensional human mammary prosthetic breast support and method of implanting
Inventor: DE BRUIJN HANS
IPC: A61F2/12
Filed: 2008-06-24
Abstract: A human mammary prosthetic support (5) is disclosed. The support comprises a continuous sheet of biocompatible mesh formed into a three-dimensional cup shape before implantation. The support is securable between the skin and the glandular structure of a human breast and includes an aperture (67) through which the nipple-areola structure is locatable. A kit is also disclosed including the support (5) and an additional guide of complimentary shape to assist implantation.
Patent NZ-588193-A (NZ)
Title: Head Flashing with drain holes
Inventor: OLDS MICHAEL JAMES
IPC: E06B1/62
Filed: 2010-09-24
Abstract: 588193 An elongate head flashing 1 for a building having a wall including a cavity 23 defined by an exterior cladding 21 and an interior membrane 24, comprises a body which in cross-section which has a first end 13 adapted to engage the cladding 21, and a second end generally opposing the first end and including a flexible portion 15 adapted to engage the membrane 24. The flashing 1 further comprises a plurality of ventilation holes 14 along its length which, in use, provide a ventilation path between the cavity 23 and the exterior of the building. The body is further adapted to engage a frame substantially between the ventilation holes 14 and the second end.
Patent NZ-588794-A (NZ)
Title: Solid pharmaceutical formulation comprising cilostazol, starch and an organic acid
Inventor: MUKAI TADASHI
IPC: A61K9/16
Filed: 2009-05-14
Abstract: Disclosed is a solid pharmaceutical formulation comprising (a) cilostazol, (b) (b) a pre-gelatinized starch in an amount of 10 to 90 percent by weight based on the whole weight of the formulation, (c) one or more kinds of enteric ingredients selected from the group consisting of hydroxypropyl methylcellulose acetate succinate, hydroxypropyl methylcellulose phthalate, carboxymethylethylcellulose, methacrylic acid copolymer L and methacrylic acid copolymer S, and (d) an organic acid, as a matrix.
Patent NZ-592114-A (NZ)
Title: Composition comprising sortase anchored surface proteins of streptococcus uberis
Inventor: LEIGH JAMES
IPC: A61K39/09
Filed: 2009-10-06
Abstract: Disclosed is an immunogenic composition comprising one or more Streptococcus uberis sortase-anchored proteins, or an immunogenic part thereof, wherein the composition is capable of eliciting an immune response, when administered to a subject. Further disclosed is a pharmaceutical composition comprising one or more Streptococcus uberis sortase-anchored proteins, or part thereof, in combination with a pharmaceutically acceptable carrier or excipient, the use of said proteins in the preparation of a medicament for eliciting an immune response in a human or non-human animals, and a method for protecting a non-human animal from the effects of infection by Streptococcus uberis comprising administering said composition.
Patent NZ-595602-A (NZ)
Title: Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
Inventor: GOKARAJU GANGA RAJU
IPC: A01N31/00
Filed: 2010-04-26
Abstract: Disclosed herein are substituted selenophenes of the formula I or II, wherein the substituents are denoted in the specification, and the use thereof in the treatment of cancer. Exemplary compounds include: 4-[(dimethylamino)diazenyl]-5-methylselenophene-2-carboxamide; 3-[(dimethylamino-diazenyl]selenopheno[2,3-b]pyridine-2-carbozamide; and 3-[(dimethylamino)dizenyl]-5-(tert-butyl)selenophene-2-carbonitrile.
Patent NZ-599300-A (NZ)
Title: Magnesium compositions and uses thereof
Inventor: LIU GUOSONG
IPC: A61K31/225
Filed: 2008-03-24
Abstract: IP No. 599300 The disclosure relates to a magnesium-containing composition formulated for oral consumption by a subject comprising magnesium threonate. wherein said magnesium threonate is present in an amount that is effective to treat a condition selected from the group consisting of: a neurological disorder, fatigue, anxiety, diabetes and magnesium deficiency and wherein said composition is formulated as a gel, semi-liquid, semi-solid, solid, tablet, capsule, beverage, a solid food, or a semisolid food.
Patent NZ-601714-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12N1/16
Filed: 2010-05-18
Abstract: Patent No. 601714 Disclosed is a method comprising: contacting a low molecular weight sugar, in a medium, with a sheet comprisingoxidized biomass fibers and a fermenting microorganism immobilized on the fibers, and fermenting at least a portion of the low molecular weight sugar utilizing the fermenting microorganism to an organic acid wherein the biomass fibers have been oxidized in an oxidizing medium by a method selected from the group consisting of radiation, chemical oxidation, sonication and pyrolysis.
Patent NZ-607035-A (NZ)
Title: Quaternary ammonium salts as a conversion coating or as anticorrosive additive in paints
Inventor: BEDARD THOMAS
IPC: C09D5/08
Filed: 2005-12-09
Abstract: Disclosed herein is and anticorrosive paint comprising: (a) as a separate compound, at least one quaternary ammonium salt containing a non- halogen anion and having the formula (I), wherein R1 is an optionally aryl-substituted C1-20 alkyl group, and R2 is an optionally aryl-substituted C1-20 alkyl group, R3 and R4 independently of each other are C1-4 alkyl groups, Xn- is an anion selected from the group consisting of hydroxide, carbonate, bicarbonate, phosphates, phosphites, hypophosphite, nitrate, sulfates, borates, anions of saturated and unsaturated acyclic C1-20 monocarboxylic acids, anions of saturated and unsaturated acyclic C2-20 dicarboxylic acids and anions of hydroxy-substituted carboxylic acids, and n denotes the appropriate number of negative charges of said anion. Also disclosed is a one-step method for improving corrosion resistance and paint adhesion to the surface of a metal substrate, comprising contacting the substrate with a composition comprising an aqueous solution of at least one quaternary ammonium salt having the formula (I).